Three Decades of Evidence on Pulsatile Cardiopulmonary Bypass in Pediatrics: No Significant Clinical Benefit

Akif Ündar1,2,3,4, Marc J Lussier1, Srihari Rajesh1

  • 1Penn State Hershey Pediatric Cardiovascular Research Center, Penn State College of Medicine, Hershey, PA, USA.

Insights

Pulsatile cardiopulmonary bypass (CPB) shows no significant clinical benefits for pediatric patients with congenital heart defects. While not harmful, this technique does not improve short-term or long-term outcomes compared to nonpulsatile flow.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Biomedical Engineering

Background:

  • Extensive expertise in in-vitro, in-vivo, and clinical trials informs this research on pulsatile cardiopulmonary bypass (CPB).
  • Over 30 years of experience guide the analysis of pulsatile CPB's role in pediatric cardiac surgery.

Purpose of the Study:

  • To evaluate the efficacy and clinical outcomes of pulsatile cardiopulmonary bypass (CPB) in pediatric and neonatal patients.
  • To synthesize evidence from peer-reviewed studies on optimizing CPB circuitry for pulsatile flow in young patients.

Main Methods:

  • Conducted a comprehensive literature search of PubMed using keywords: "Pulsatile flow," "Cardiopulmonary Bypass," "Vital Organ Injury," "Clinical outcomes," "Pediatrics," "Neonates and infants."
  • Analyzed 88 peer-reviewed studies published between 1996 and 2025, including randomized clinical trials and retrospective analyses.
  • Included data from a randomized clinical trial of 159 patients and a retrospective study of 284 patients at Penn State Health Children's Hospital.

Main Results:

  • Neonatal piglet models showed improved cerebral hemodynamics with pulsatile flow and deep hypothermic circulatory arrest.
  • Randomized clinical trials and retrospective studies questioned the efficacy of pulsatile flow in clinical settings.
  • A rigorous randomized trial (159 patients) and retrospective study (284 patients) found no significant clinical advantage of pulsatile over nonpulsatile flow.
  • Pulsatile flow did not demonstrate measurable benefits but also did not result in adverse outcomes in clinical trials.

Conclusions:

  • Current evidence indicates that pulsatile cardiopulmonary bypass (CPB) does not offer significant short-term or long-term advantages for pediatric patients undergoing congenital heart surgery.
  • While pulsatile CPB is not associated with adverse outcomes, its clinical utility in this population remains unproven.
  • Further research may be needed to identify specific subgroups or conditions where pulsatile flow might confer benefits.

Related Concept Videos

The Evidence for Evolution02:55

The Evidence for Evolution

Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.3K
Benefits of Self-Esteem01:25

Benefits of Self-Esteem

Self-esteem—an individual's overall evaluation of their worth—plays a complex role in psychological functioning and well-being. It is often associated with many positive traits, such as confidence, optimism, and perseverance. Individuals with high self-esteem typically experience better sleep, manage peer pressure more effectively, and report greater life satisfaction. Conversely, low self-esteem has been consistently linked with increased risks of depression, anxiety, and poor...
203
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
734
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
709
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
833
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
674